InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Explore the detailed record of transactions filed by Hill Emily Luisa, Directrice Financière. Director active across 1 company, notably PTC Therapeutics, INC.. Cumulatively, 9 disclosures have been recorded. Breakdown: 0 buy · 9 sells. Total volume traded: €391k. Activity tracked since 4 January 2022. The latest transaction was filed on 31 March 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
7,910 shares@ US$37.7780.0044% mcap69.0% of flowCommon StockSEC:0001415889-22-003564:0
553 shares@ US$40.0020.0003% mcap5.0% of flowCommon StockSEC:0001179110-22-000837:0
553 shares@ US$40.0020.0003% mcap32.5% of flowCommon StockSEC:0001179110-22-000837
211 shares@ US$39.3140.0001% mcap1.9% of flowCommon StockSEC:0001179110-22-000629:0
211 shares@ US$39.3140.0001% mcap12.1% of flowCommon StockSEC:0001179110-22-000629
800 shares@ US$38.5250.0004% mcap45.0% of flowCommon StockSEC:0001179110-22-000398
800 shares@ US$38.5250.0004% mcap7.0% of flowCommon StockSEC:0001179110-22-000398:0
173 shares@ US$41.1620.0001% mcap1.6% of flowCommon StockSEC:0001179110-22-000303:0
173 shares@ US$41.1620.0001% mcap10.4% of flowCommon StockSEC:0001179110-22-000303
9 of 9 declarations
About Hill Emily Luisa
Emily Luisa Hill is the Chief Financial Officer at PTC THERAPEUTICS, INC. She oversees the financial management of the company, ensuring that resources are used effectively to achieve strategic objectives. Her role is essential in ensuring the financial health of the company.
